Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement - North of England - Tranche B

NHS England

This public procurement record has 2 releases in its history.

Award

25 Mar 2020 at 08:39

Award Notice
Tender

07 Oct 2019 at 11:31

Tender Notice
Summary of the contracting process

The contracting process is mandated by NHS England for the NHS Framework Agreement focused on Branded Medicines, specifically covering Cytokine Modulators and monoclonal antibodies. This multi-region procurement is classified under pharmaceutical products and is intended for the North of England. The contract commenced on 1st March 2020 and is scheduled to end on 28th February 2022, with options for extension at the discretion of the authority. The tender period concluded on 7th November 2019, and it has been processed through an open procurement method above the threshold.

This tender presents significant growth opportunities for businesses specialising in pharmaceutical products, particularly those offering branded medicines. Small and medium enterprises (SMEs) are encouraged to participate, as the bidding process is not exclusive to larger companies. Companies involved in the development or distribution of cytokine modulators, monoclonal antibodies, or related pharmaceuticals would be well-suited to compete for this contract, which promises a substantial value of approximately £514 million.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement - North of England - Tranche B

Notice Description

NHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other monoclonal Antibodies, and Fondaparinux Offer reference number: CM/PHR/16/5527 CM/PHR/16/5527/01: NHS Framework for the NHS North Of England Region, Branded Medicines, Tranche B, 1 March 2020 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5527/02: NHS Framework for the NHS North Of England Region, Branded Medicines Annual Tranche, Cytokine Modulators and other monoclonal antibodies, 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5527/03: NHS Framework agreement for Fondaparinux London, 1 March 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. South of England, 1 March 2020 to 31 August 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Midlands and East, 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/75186bcb-ea47-4cda-a461-9737cdf49bbe
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£514,043,196 £100M-£1B
Lots Value
Not specified
Awards Value
£205,535,556 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
25 Mar 20206 years ago
Submission Deadline
7 Nov 2019Expired
Future Notice Date
Not specified
Award Date
13 Feb 20206 years ago
Contract Period
1 Mar 2020 - 28 Feb 2022 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
35
Supplier Names

Acre Pharma Limited

Amgen Ltd

ASPEN PHARMA LTD

Astellas Pharma Ltd

SANOFI-AVENTIS UK HOLDINGS LIMITED

Bayer Plc

Biogen Idec Limited

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED

Celltrion Healthcare

Daiichi Sankyo UK Ltd

DR. REDDY'S LABORATORIES (EU) LIMITED

Eli Lilly & Company Ltd

Ferring Pharmaceuticals Ltd

Gedeon Richter UK Ltd

Mylan

Gilead Sciences Ltd

Ipsen

Janssen-Cilag Ltd

Merck Serono Limited

MSD

NAPP LABORATORIES LIMITED

Novartis Pharmaceuticals UK Limited

Novo Nordisk

Pfizer Ltd

Pharmasure Ltd

Profile Pharma Ltd

Roche Products Ltd

ROVI Biotech Ltd

Sandoz Ltd

Takeda UK Limited

Techdow Pharma England Ltd

Teva UK Limited

Theramex HQ UK

Typharm Ltd

UCB Pharma Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...